Quantitative approaches to drug development
Quantitative approaches to drug development
We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives. Science and Services
About
Pharmetheus reduces uncertainty in all phases of drug development.
News
– These changes are natural progressions towards our long-term strategy. Our leadership team is broadening its competencies and perspectives, reinforcing Pharmetheus’ positioning as an important contributor in the advancement of quantitative disciplines, ensuring continued growth and success for our sector within the industry, says Peter Milligan, CEO. As part of this transition, Pharmetheus announces the addition of key leaders to…
Joining the board are Sverre Bengtsson and Marie Sandström, both bringing extensive experience and invaluable insights to the Pharmetheus Board of Directors. Sverre Bengtsson, renowned for his product development acumen as founder at Viedoc, joins as a board member, strengthening the company’s strategic direction with his deep understanding of product innovation and commercialization. Sverre Bengtsson comments on his appointment: –…
In this article, Jakob Ribbing and co-authors under the ISoP Standards & Best Practice Committee, present perspectives on best practices for covariate analyses, aiming to guide pharmacometrics decision making. With an abundance of sources to learn from, the need for a summary was identified. Through covering several aspects of covariate analysis that are common to (nearly) all approaches outlined, along…
Science & Services
How we work
Traceability, accountability, and independent quality control are of utmost importance to us, and embedded in our way of working.
Publications
Explore our scientific publications.
Explore our web
Model Informed Drug Development
A quantitative framework to support and inform development program strategies and decisions.
“Sharing with colleagues is why I love working here”
Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.
History of Pharmetheus
Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.